title: Self-reported efficacy of cannabis and other complementary medicine modalities by Parkinson's disease patients in colorado.
abstract: Introduction. Complementary and alternative medicine (CAM) is frequently used by Parkinson's disease (PD) patients. We sought to provide information on CAM use and efficacy in PD patients in the Denver metro area with particular attention to cannabis use given its recent change in legal status. Methods. Self-administered surveys on CAM use and efficacy were completed by PD patients identified in clinics and support groups across the Denver metro area between 2012 and 2013. Results. 207 patients (age 69 ± 11; 60% male) completed the survey. Responses to individual CAM therapy items showed that 85% of respondents used at least one form of CAM. The most frequently reported CAMs were vitamins (66%), prayer (59%), massage (45%), and relaxation (32%). Self-reported improvement related to the use of CAM was highest for massage, art therapy, music therapy, and cannabis. While only 4.3% of our survey responders reported use of cannabis, it ranked among the most effective CAM therapies. Conclusions. Overall, our cross-sectional study was notable for a high rate of CAM utilization amongst PD patients and high rates of self-reported efficacy across most CAM modalities. Cannabis was rarely used in our population but users reported high efficacy, mainly for nonmotor symptoms.
authors.affiliation: Deptartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
authors.forename: Taylor Andrew
authors.initials: TA
authors.lastname: Finseth
authors.affiliation: Deptartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
authors.forename: Jessica Louise
authors.initials: JL
authors.lastname: Hedeman
authors.affiliation: Department of Economics, University of Colorado Denver, Denver, CO 80217, USA.
authors.forename: Robert Preston
authors.initials: RP
authors.lastname: Brown
authors.affiliation: Colorado School of Public Health, University of Northern Colorado, Greeley, CO 80639, USA.
authors.forename: Kristina I
authors.initials: KI
authors.lastname: Johnson
authors.affiliation: Deptartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
authors.forename: Matthew Sean
authors.initials: MS
authors.lastname: Binder
authors.affiliation: Deptartment of Neurology, University of Colorado Anschutz Medical Campus, Aurora, CO 80045, USA.
authors.forename: Benzi M
authors.initials: BM
authors.lastname: Kluger
references.citation: Mov Disord. 2008 Apr 15;23(5):690-9
references.pmid: 18228568
references.citation: Mov Disord. 2010 Oct 15;25(13):2094-8
references.pmid: 20721921
references.citation: PLoS One. 2014 Apr 15;9(4):e94078
references.pmid: 24736474
references.citation: J Biomed Inform. 2009 Apr;42(2):377-81
references.pmid: 18929686
references.citation: Neurology. 2004 Oct 12;63(7):1245-50
references.pmid: 15477546
references.citation: Clin Neurol Neurosurg. 2009 Feb;111(2):156-60
references.pmid: 18977584
references.citation: Neuroepidemiology. 2011;36(1):46-51
references.pmid: 21196772
references.citation: J Clin Neurosci. 2013 Aug;20(8):1062-7
references.pmid: 23815871
references.citation: Complement Ther Clin Pract. 2005 Aug;11(3):161-71
references.pmid: 16005833
references.citation: Mov Disord. 2004 Sep;19(9):1102-6
references.pmid: 15372606
references.citation: Natl Health Stat Report. 2008 Dec 10;(12):1-23
references.pmid: 19361005
references.citation: Neurology. 2001 Sep 11;57(5):790-4
references.pmid: 11552005
references.citation: NCHS Data Brief. 2014 Apr;(146):1-8
references.pmid: 24750666
references.citation: J Am Osteopath Assoc. 2012 Jan;112(1):22-8
references.pmid: 22302743
references.citation: Mov Disord. 2015 Mar;30(3):313-27
references.pmid: 25649017
references.citation: J Psychopharmacol. 2009 Nov;23(8):979-83
references.pmid: 18801821
references.citation: Addiction. 2003 Nov;98(11):1493-504
references.pmid: 14616175
references.citation: Clin Neuropharmacol. 2014 Mar-Apr;37(2):41-4
references.pmid: 24614667
references.citation: Headache. 2011 Jul-Aug;51(7):1087-97
references.pmid: 21649654
references.citation: J Neurol Neurosurg Psychiatry. 1990 May;53(5):436
references.pmid: 2351975
references.citation: Int J Clin Pract. 2012 Oct;66(10):924-39
references.pmid: 22994327
references.citation: JAMA Neurol. 2014 May;71(5):543-52
references.pmid: 24664227
references.citation: Neurology. 2014 Apr 29;82(17):1556-63
references.pmid: 24778283
references.citation: J Psychoactive Drugs. 2011 Apr-Jun;43(2):128-35
references.pmid: 21858958
references.citation: Mov Disord. 2006 Jan;21(1):86-9
references.pmid: 16108030
references.citation: Mov Disord. 2014 Apr;29(4):539-45
references.pmid: 24375468
references.citation: N Engl J Med. 1993 Jan 21;328(3):176-83
references.pmid: 8417384
references.citation: Am J Med. 2002 May;112(7):566-71
references.pmid: 12015249
references.citation: BMC Complement Altern Med. 2005 Jun 02;5:11
references.pmid: 15932647
references.citation: Neurology. 2001 Jun;56(11 Suppl 5):S1-S88
references.pmid: 11402154
references.citation: Epilepsy Behav. 2014 May;34:73-6
references.pmid: 24726950
references.citation: Curr Neurol Neurosci Rep. 2014 Jun;14(6):451
references.pmid: 24760476